Journal of Clinical Microbiology · 2015 · 14 citations · 3 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsBacterial PathogenesisResistance In Gram-negative BacteriaAntibacterial Susceptibility TestingAntibiotic Susceptibility Data AnalysisAntibiotic Susceptibility TestingAntimicrobial Susceptibility InterpretationEscherichia ColiMicrobiological BreakpointsPseudomonas Aeruginosa ResistanceResistance Breakpoints
The CLSI reduced the cefepime Enterobacteriaceae susceptibility breakpoint and introduced the susceptible-dose-dependent (S-DD) category. In this study, MICs were determined for a Gram-negative collection to assess the impact of this change. For Enterobacteriaceae, this resulted in <2% reduction in susceptibility, with 1% being S-DD. If applied to Pseudomonas aeruginosa, the % susceptibility (%S) dropped from 77% to 43%, with 34% being S-DD. The new breakpoints did little to the Enterobacteriaceae %S, but for P. aeruginosa, a profound reduction was seen in %S. The recognition of a S-DD response to cefepime should alert clinicians to the possible need for higher doses.
3